Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Acta Diabetologica
Published in: Acta Diabetologica 6/2014

01-12-2014 | Case Report

Successful desensitization in patient with type 2 diabetes with an insulin allergy using insulin pump and glargine

Authors: G. Petrovski, M. Zivkovic, T. Milenkovic, I. Ahmeti, I. Bitovska

Published in: Acta Diabetologica | Issue 6/2014

Login to get access

Excerpt

Insulin allergy is rare, but they can occur in patients starting insulin therapy. There are different insulin desensitization protocols where insulin is diluted and given to the patient in small doses for a period of couple of days. …
Literature
1.
2.
Sola-Gazagnes A, Pecquet C, Allergie à l’insuline en (2003) Journées de Diabétologie de l’Hôtel Dieu. Flammarion Médecine-Sciences 2004:161–179
3.
Ping W, Cheng J, Mingli W et al (2013) Desensitization of allergy to human insulin and its analogs by administering insulin aspart and insulin glargine. Annales d’Endocrinologie 74:56–58
4.
Thompson DM, Ronco JJ (1993) Prolonged desensitization required for treatment of generalized allergy to human insulin. Diabetes Care 16:957–958PubMed
5.
Naf S, Esmatjes E, Recasens M, Valero A, Halperin I, Levy I, Gomis R (2002) Continuous subcutaneous insulin infusion to resolve an allergy to human insulin. Diabetes Care 25:634–635PubMedCrossRef
Metadata
Title
Successful desensitization in patient with type 2 diabetes with an insulin allergy using insulin pump and glargine
Authors
G. Petrovski
M. Zivkovic
T. Milenkovic
I. Ahmeti
I. Bitovska
Publication date
01-12-2014
Publisher
Springer Milan
Published in
Acta Diabetologica / Issue 6/2014
Print ISSN: 0940-5429
Electronic ISSN: 1432-5233
DOI
https://doi.org/10.1007/s00592-014-0591-1

Other articles of this Issue 6/2014

Acta Diabetologica 6/2014 Go to the issue

Original Article

Modulation of coronary heart disease risk by insulin resistance in subjects with normal glucose tolerance or prediabetes

Original Article

Serum ferritin, diabetes, diabetes control, and insulin resistance

Original Article

An assessment of the impact of type 2 diabetes on the quality of life based on age at diabetes diagnosis

Original Article

Pulse wave reflection is associated with diabetes duration, albuminuria and cardiovascular disease in type 1 diabetes

Review Article

Updating the natural history of diabetic nephropathy

Review Article

Harnessing the immunological properties of stem cells as a therapeutic option for diabetic nephropathy

ACC 2024 Congress Coverage

Heart Failure Video

Year in Review: Heart failure and cardiomyopathies

Watch now

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits